The North Carolina Biotechnology Center, the University of North Carolina at Charlotte and Carolinas Medical Center are hosting "Nanotechnology in Biology and Medicine," a one-day conference on nanotechnology's potential impact on medicine on November 5, 2007.
Moving beyond carbon nanotubes, researchers are developing insights into a remarkable class of tubular nanomaterials that can be produced in water with a high degree of control over their diameter and length.
NanoSafe presentation will provide a 2007 update on the practical five-point risk management approach developed with industry, academia, and the National Institute for Occupational Safety and Health (NIOSH).
In an important step toward realizing the potential of radionuclide-loaded nanoparticles as radiotherapeutic agents, scientists have demonstrated that ultrashort carbon nanotubes will permanently entrap the potent alpha particle emitting element astatine-211, which has a half-life of 7.2 hours.
A new targeted drug delivery method, which combines two nanoparticles into one larger one, uses ultrasound to image tumors and release the anticancer drug doxorubicin from "nanobubbles" into the same tumors.
Take a quantum dot, add a coating of poly(ethylene glycol) (PEG), and attach a homing peptide and a piece of small interfering RNA (siRNA), and the result is a targeted nanoparticle that can stop the production of a specific protein by a targeted cell.